Estrogens, homocysteine, vasodilatation and menopause: basic mechanisms, interactions and clinical implications

Estrogens influence the independent cardiovascular risk factor homocysteine as well as vasodilatation. Homocysteine alone also influences vasodilatation, indicating a relational triangle that seems important in interpreting the isolated effects of estrogens on homocysteine metabolism and vasoreactiv...

Full description

Saved in:
Bibliographic Details
Published in:Gynecological endocrinology 2003-08, Vol.17 (4), p.339-354
Main Authors: SMOLDERS, R. G. V, VAN DER MOOREN, M. J, SIPKEMA, P, KENEMANS, P
Format: Article
Language:English
Subjects:
Biological and medical sciences
Cardiovascular Diseases - physiopathology
Cardiovascular Diseases - prevention & control
Clinical Trials as Topic
Estrogen Replacement Therapy
Estrogens - physiology
Female
Fundamental and applied biological sciences. Psychology
Homocysteine - metabolism
Homocysteine - physiology
Humans
Mammalian female genital system
Morphology. Physiology
Postmenopause - physiology
Vasodilation - physiology
Vertebrates: reproduction
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Estrogens influence the independent cardiovascular risk factor homocysteine as well as vasodilatation. Homocysteine alone also influences vasodilatation, indicating a relational triangle that seems important in interpreting the isolated effects of estrogens on homocysteine metabolism and vasoreactivity. This paper gives an overview of the current understanding regarding vasoreactivity, homocysteine metabolism and the role of estrogens. This is placed against the background of the clinical trials on the effect of postmenopausal hormone replacement therapy on homocysteine levels and addresses the importance of the interaction between homocysteine, estrogens and vasoreactivity.
ISSN:0951-3590
1473-0766
DOI:10.1080/713603288